Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: Correlation with colony assay

International Journal of Biological Markers

Volumn 17, Issue 4, 2002, Pages 259-267

  Moretti, S ^a,b   Dabusti, M ^a,b   Castagnari, B ^a,b   Tieghi, A ^a,b   Ferrari, L ^a,b   Campioni, D ^a,b   Punturieri, M ^a,b   Dominici, M ^a,b   Castoldi, G L ^a,b   Lanza, Francesco ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b International Cancer Centre   (Italy)

Author keywords

CD34+ cells; Clonogenic assay; Cord blood; Flow cytometry; Mobilized blood

Indexed keywords

ACID CITRATE DEXTROSE; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACCURACY; ADULT; ANALYZER; APHERESIS; ARTICLE; CANCER REGRESSION; CANCER STAGING; CELL COUNT; CLINICAL TRIAL; CLONOGENIC ASSAY; COLONY FORMING UNIT GM; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROBLAST; FEMALE; FLOW CYTOMETRY; HEMATOLOGY; HEMATOPOIETIC STEM CELL; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; METHODOLOGY; NONHODGKIN LYMPHOMA; PREDICTION; STANDARD; STANDARDIZATION; STEM CELL MOBILIZATION; THROMBOSIS; UMBILICAL CORD BLOOD; VALIDATION PROCESS;

EID: 12244259755     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.5044     Document Type: Article

References (45)

1. Krause D, Fackler MJ, May S. CD34: Structure, biology and clinical utility. Blood 1996; 87: 1-16.
2. Lanza F, Sutherland R. Structure and biology of the CD34 molecule. J Biol Regul Homeost Agents 2001; 15: 1-13.
3. Aglietta M, Lanza F, Lemoli R, et al. Peripheral blood stem cells in acute myeloid leukemia: Biology and clinical applications. Haematologica 1996; 81: 77-92.
4. Cheng J, Baumhueter S, Cacalano G, et al. Hematopoietic defects in mice lacking the sialomucin CD34. Blood 1996; 87: 479-90.
5. Suzuki A, Andrew D, Gonzalo J, et al. CD34 deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel cross-reactive 90 KD protein. Blood 1996; 87: 3550-62.
6. Greaves MF, Colman SM, Bühring HJ, et al. Report on the CD34 cluster workshop. In: Schlossman SF, Boumsell L. Gilks W, et al, eds. Leucocyte Typing V: White Cell Differentiation Antigens. Oxford, UK: Oxford University Press 1995; 840-50.
7. Lanza F., Moretti S., Papa S, et al. Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993. Haematol 1994; 79: 374-86.
8. Sutherland DR, Marsh JCW, Davidson J, et al. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells. Exp Hematol 1992; 20: 590-9.
9. Cannovo N, Bossy D, Hirn J. Significant diversity of the reactivity of monoclonal CD34 antibodies requires an extended classification of the CD34 epitopes. Lab Hematol 1997; 3: 253-60.
10. Serke S, Huhn D. Expression of class I, II, and III epitopes of the CD34 antigen by normal and leukemic hemopoietic cells. Cytometry 1996; 26: 154.
11. Lanza F, Moretti S, Castagnari B, et al. CD34+ leukemic cells assessed by different CD34 monoclonal antibodies. Leuk Lymphoma 1995; 18 (suppl 1): 25-30.
12. Serke S, Watts M, Knudsen L, et al. In vitro clonogenicity of mobilized peripheral blood CD34-expressing cells: Inverse correlation to both relative and absolute numbers of CD34-expressing cells. Br J Haematol 1996; 95: 234-40.
13. Serke S, Arseniev L, Watts M, et al. Imprecision of counting CFU-GM colonies and CD34-expressing cells. Bone Marrow Transplant 1997; 20: 57-61.
14. Poncelet P, George F, Papa S, Lanza F. Quantitation of hemopoietic cell antigens in flow cytometry. Eur J Histochem 1996; 40 (suppl 1): 15-32.
15. Siena S, Bregni M, Di Nicola M, et al. Milan protocol for clinical CD34+ estimation in peripheral blood for autografting in patients with cancer. In: Wunder E, Serke S, Sovalat H, Henon P, eds. Haematopoietic Stem Cells: The Mulhouse Manual. Dayton: Alpha Med Press 1994; 23-30.
16. Sutherland R, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34 cell determination by flow cytometry. J Hematother 1996; 3: 213-26.
17. Weinberg D. Qbend10 (CD34) antibody is unsuitable for routine use in the ISHAGE CD34+ cell determination assay. J Hematother 1996; 5: 599-600.
18. McNiece I, Kern B, Zilm K, et al. Minimization of CD34+ cell enumeration variability using the ProCOUNT standardized methodology. J Hematother 1998; 7: 499-504.
19. Keeney M, Gratama JW, Chin-Yee IH, et al. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry - Time to let go! Cytometry 1998; 34: 280-3.
20. Gorman MRG, Thomas J. Isotype controls - Time to let go? Cytometry 1999; 38: 78-80.
21. Lanza F, Campana D, Knapp W, et al. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Eur J Histochem 1996; 40: 7-14.
22. Sutherland DR, Anderson L, Keeney M, et al. Toward a worldwide standard for CD34+ enumeration. J Hematother 1997; 6: 85-9.
23. Sovalat H, Wunder E, Tienhaara A, et al. Commentary: Prospects for standardization of stem cell determination within Europe. J Hematother 1994; 3: 293-6.
24. Gratama JW, Barnett D, Brando B, et al. Flow cytometric enumeration of CD34+ hematopoietic stem cells. Cytometry 1998; 34: 128-42.
25. Orfao A, Schmitz G, Basso G, et al. for the Standardization Committee on Clinical Flow Cytometry of the International Federation of Clinical Chemistry. Flow cytometric immunophenotyping of hematological malignancies. Clin Chem 1999; 45: 1708-17.
26. Lanza F, Campana F, Knapp W, et al. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Eur J Histoch 1996; 40 (suppl 1): 7-14.
27. Stewart AK, Imrie K, Keating A, et al. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections. Exp Hematol 1995; 23: 1619-27.
28. Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 1998; 34: 61-70.
29. Leuner S, Arland M, Kahl C, et al. Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: Comparison of a volumetric assay and the ISHAGE gating strategy. Bone Marrow Transplant 1998; 22: 699-706.
30. Gratama JW, Braakman E, Kraan J, et al. Comparison of single and dual platform assay formats for CD34+ haematopoietic progenitor cell enumeration. Clin Lab Haem 1999; 21: 337-46.
31. Barnett D, Janossy G, Lubenko A, et al. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Clin Lab Haem 1999; 21: 301-8.
32. Barnett D, Granger V, Storie I, et al. Quality assessment of CD34+ stem cell enumeration: Experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br J Haematol 1998; 102: 553-65.
33. Barnett D, Granger V, Kraan J, et al. for and on behalf of the European Working Group on Clinical Cell Analysis. Reduction of intra- and inter-laboratory variation in CD34+ stem cell enumeration by the use of stable test material, standard protocol and targeted training. Br J Haematol 2000; 108: 784-92.
34. Gratama J, Sutherland DR, Keney M, Papa S. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. J Biol Regul Homeost Agents 2001; 15: 14-22.
35. Olivero S, Alario T, Ladaique P, et al. CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol. Bone Marrow Transplant 1999; 23: 387-94.
36. Brockkebank AM, Sparrow RL. Enumeration of CD34+ cells in cord blood: A variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry 2001; 46: 254-61.
37. Titley I, Healy LE, Scott M, Amos TA, Gordon MY. Extent of variability inherent in measurements of CD34-positive cells in different human hemopoietic tissues. Bone Marrow Transpl 1995; 16: 611-6.
38. Rudin C, Garland J, Joyner M, et al. Concordant expression of class II and class IIICD34 epitopes on haemopoietic cells in leukapheresis and cord blood samples with CD45/CD34 dual staining. Br J Haematol 1997; 97: 488-91.
39. Hubl W, Iturraspe J, Martinez GA, et al. Measurement of absolute concentration and viability of CD34+ cells in cord blood and cord blood products using fluorescent beads and cyanine nucleic acid dyes. Cytometry 1998; 34: 121-7.
40. Sutherland R, Keating A, Nayar R, et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994; 22: 1003-10.
41. Menendez P, Redondo O, Rodriguez A, et al. Comparison between a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry 1998; 34: 264-71.
42. D'Arena G, Musto P, Cascavilla N, Scalzulli PR, Dello Iacono N, Carotenuto M. Circulating CD34+ absolute cell number is the best single parameter to predict the quality of leukapheretic yield. Bone Marrow Transplant 1998; 22: 215-6.
43. Lanza F, Campioni D, Moretti S, et al. CD34+ cell subsets and long-term culture colony-forming cells (LTC-CFC) evaluated on both autologous and normal bone marrow stroma predict long-term h ematopoietic engraftment in patients receiving autologous peripheral blood stem cell transplantation. Exp Hematol 2001; 29: 1484-93.
44. Chang H, Jensen L, Quesenberry P, Bertoncello I. Standardization of hematopoietic stem cell assays: A summary of a workshop and working group meeting sponsored by the National Heart, Lung and Blood Institute held at the National Institutes of Health, Bethesda, MD on September 8-9, 1998 - July 30, 1999. Exp Hematol 2000: 28; 743-52.
45. Mossuz P, Dobo I, Genevay M, et al. Use of collagen for standardization of PBSC graft quality evaluation: A multicenter comparative analysis of commercial collagen based and methylcellulose based colony forming unit (CFU) assay kits. J Hematother 1998; 7: 351-9.